Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas

Area of Science:

• Oral Pathology
• Oncology
• Biochemistry

Background:

• Ameloblastoma, the most common odontogenic tumor, presents as a benign but locally invasive neoplasm.
• Syndecan-1, a cell surface proteoglycan, plays a role in cell adhesion and is often downregulated in cellular transformation.
• Understanding factors influencing ameloblastoma behavior is crucial for effective management.

Purpose of the Study:

• To investigate syndecan-1 expression patterns in ameloblastomas.
• To assess and compare the proliferating activity (Ki-67) in solid/multicystic (SA) and unicystic ameloblastomas (UA).
• To explore the correlation between syndecan-1 expression and the biological behavior of different ameloblastoma subtypes.

Main Methods:

• Immunohistochemical analysis of syndecan-1 and Ki-67 expression.
• Study included 120 ameloblastoma cases: 75 SA and 45 UA.
• Statistical analysis to compare expression levels and correlate with histological subtypes.

Main Results:

• Syndecan-1 expression was significantly lower in SA (40.2%) compared to UA (49.7%) (p<0.05).
• Ki-67 proliferation index was similar in both SA and UA subtypes.
• No correlation was found between syndecan-1 expression and Ki-67 index.

Conclusions:

• Reduced syndecan-1 expression in SA suggests a more aggressive biological behavior compared to UA.
• The differing histomorphologies of SA and UA may explain the lack of correlation between syndecan-1 and Ki-67.
• Further research is needed to fully elucidate the role of syndecan-1 in ameloblastoma pathogenesis.